Skip to search formSkip to main contentSkip to account menu

buclosamide

Known as: 4-chloro-2-hydroxybenzoic acid-n-butylmide, N-butyl-4-chlorsalicylamide 
A topical antimycotic agent for the treatment of dermatomycoses.
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Salicylamides

Narrower (1)

jadit

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1983
1983
Studies on purity and stability of photopatch test substances
19 photo substances were studied by thin‐layer chromatography (TLC) as fresh solutions, and during storage under various… 
1974
1974
Topical therapy with Jadit (buclosamide) in dermatomycoses.
1974
1974
Topical therapy with Jadit (buclosamide) in dermatomycoses.
1970
1970
Persistent light reactions from buclosamide.
Two cases of localized persistent light reactions from buclosamide (ingredient of Jadit [United Kingdom]) are reported. These… 
1970
1970
A clinical trial with a new topical antimycotic agent 4-chloro-2-hydroxybenzoic acid-n-butylmide i.e. buclosamide.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)